Results and presentations

Home / Investor relations / Results and presentations


Latest results announcements and presentations


2024


Meet AZN Management: Weight Management Virtual Event

4 November 2024

Webcast replay

Video


Meet AZN Management: WCLC and ESMO 2024

16 September 2024

Webcast replay

Video


Meet AZN Management: Lung Cancer and QCS

9 September 2024

Webcast replay

Video


H1 and Q2 2024 results

25 July 2024

Webcast replay

Video


Meet AZN management: American Society of Clinical Oncology 2024 Annual Meeting

3 June 2023

Webcast replay

Video



AstraZeneca Investor Day

21 May 2024

AstraZeneca Ambition 2030 Webcast replay

Video


BioPharmaceuticals Webcast replay

Video


Rare Disease Webcast replay

Video


Oncology Webcast replay

Video


Delivering Shareholder Value Webcast replay

Video



Q1 2024 results

25 April 2024

Webcast replay

Video



AZN: Sustainability 2023 Highlights Summary Call

22 March 2024

Webcast replay

Video



Full Year and Q4 2023 results

8 February 2024

Webcast replay

Video



J.P. Morgan 42nd Annual Healthcare Conference

9 January 2024

Webcast replay

Audio

2023


9M and Q3 2023 results

9 November 2023

Webcast replay

Video


Meet AZN management: European Society of Medical Oncology 2023 Annual Meeting

23 October 2023

Webcast replay

Video


Morgan Stanley 21st Annual Global Healthcare Conference

11 September 2023

GlobalMeet Webcast

Audio


2023 World Conference on Lung Cancer (WCLC) highlights

11 September 2023


H1 and Q2 2023 results

28 July 2023

Webcast replay

Video


Meet AZN management: American Society of Clinical Oncology 2023 Annual Meeting

5 June 2023

Video replay

Video


Q1 2023 results

27 April 2023

Webcast replay

Video


2023 American Association for Cancer Research (AACR) highlights

19 April 2023


2022 Sustainability Highlights

22 March 2023

Webcast replay

Video


Full Year and Q4 2022 results

9 February 2023

Webcast replay

Video


J.P. Morgan 41st Annual Healthcare Conference

9 January 2023


2022


Meet AZN management: San Antonio Breast Cancer Symposium (SABCS) 2022

8 December 2022

Webcast replay

Video


Year-to-date and Q3 2022 results

10 November 2022

Webcast replay

Video


Meet AZN Management: Alexion Rare Disease Deep Dive

6 September 2022

Webcast replay - presentation part 1

Video

Webcast replay - presentation part 2

Video

Webcast replay - Q&A Session

Video


H1 2022 results

29 July 2022

Webcast replay

Video


Meet AZN management: American Society of Clinical Oncology 2022 Annual Meeting

6 June 2022

Video replay

Video

Audio replay

Audio


Q1 2022 results

29 April 2022

Webcast replay

Video


March 2022 Roadshow presentation

16 March 2022


Meet AZN management: Leading in sustainability

7 March 2022

Importance of Governance, Ethics and Culture – webcast replay

Video

Importance of Governance, Ethics and Culture – webcast replay

Audio

Environmental Considerations – webcast replay

Video

Environmental Considerations – webcast replay

Audio


Investor science conference call: ASCO GU 2022

23 February 2022

Webcast replay

Video


Full-year and Q4 2021 results

10 February 2022

Webcast replay

Video


Investor science conference call: ASCO GI 2022

24 January 2022

Webcast replay

Video


2021


Year-to-date and Q3 2021 results

12 November 2021

Webcast replay

Video

Webcast replay

Audio


Investor science conference call: ESMO 2021

20 September 2021

Webcast replay

Video


H1 2021 results

29 July 2021

H1 2021 results - webcast replay

Video


Meet AZN management: Oncology - 2021 ASCO Annual Meeting

7 June 2021

Webcast replay

Video


Q1 2021 results

30 April 2021

Q1 2021 results - webcast replay

Video


Meet AZN management: BioPharmaceuticals

25 March 2021

Opening session and Q&A recording

Video

New CVRM: emerging pipeline recording

Video

New CVRM: near-term opportunities recording

Video

Respiratory & Immunology: emerging pipeline recording

Video

Respiratory & Immunology: near-term opportunities recording

Video


Full-year 2020 results

11 February 2021

Full-year 2020 results - webcast replay

Audio

2020


Accelerating AstraZeneca’s strategic and financial development:
AstraZeneca to acquire Alexion

12 December 2020

Webcast

Video


Year-to-date and Q3 2020 results

5 November 2020

Year-to-date and Q3 2020 results - webcast replay

Audio



Meet AZN management: Leading in sustainability

9 September 2020

Leading in sustainability - webcast replay

Video

Leading in sustainability - webcast replay

Audio


Investor science conference call: Farxiga’s DAPA-CKD trial at ESC 2020

30 August 2020

Audio replay of Farxiga’s DAPA-HF Investor Conference Call at ESC

MP3


H1 2020 results

30 July 2020


Capital markets event - Meet AZN management: ASCO 2020

1 June 2020

Opening session

MP3

Tagrisso and immuno-oncology

MP3

Enhertu and breast cancer

MP3

Lynparza

MP3

Calquence and haematology

MP3


First-quarter 2020 results

29 April 2020


Full-year and Q4 2019 results

14 February 2020


Epidemiology data update

14 February 2020

2019



Investor science conference call: American Society of Hematology 2019

10 December 2019

Investor conference science conference call – ASH 2019 audio replay

MP3


Investor science conference call: American College of Rheumatology 2019

13 November 2019

Investor science conference call - ACR 2019 audio replay

MP3


Investor science conference call: American Society of Nephrology Kidney Week 2019

11 November 2019

Investor science conference call - ASN 2019 audio replay

MP3


Year-to-date and Q3 2019 Results

24 October 2019


Investor science conference call: European Society for Medical Oncology (ESMO) Congress 2019

30 September 2019


Investor science conference call: Farxiga's DAPA-HF trial at ESC 2019

1 September 2019


H1 2019 Results

25 July 2019


‘Meet AZN management’ at 2019 ASCO Annual Meeting

3 June 2019


Q1 2019 Results

26 April 2019


Collaboration on trastuzumab deruxtecan Investor conference call

29 March 2019


Full-Year 2018 Results

14 February 2019

2018


Year-end webcast for investors and analysts on China and Emerging Markets

13 December 2018

Year-End Investor & Analyst Webcast, China and Emerging Markets video

Video


AHA Scientific Sessions 2018

12 November 2018


Year-To-Date and Q3 2018 Results

8 November 2018


H1 2018 Results

26 July 2018


AstraZeneca Investor Event at the 2018 ASCO Annual Meeting

1 June 2018


Q1 2018 Results

18 May 2018


Full-Year 2017 Results

2 February 2018


2017


Investor science event: Late-stage pipeline webcast

14 December 2017


Year-To-Date and Q3 2017 Results

9 November 2017


AstraZeneca Investor Science Event at ERS 2017

13 September 2017


AstraZeneca Investor Science Event at ESMO 2017

8 September 2017


H1 2017 Results

27 July 2017


AstraZeneca Investor Science Event at 2017 ASCO Annual Meeting

5 June 2017


Q1 2017 Results

27 April 2017


Full-Year and Q4 2016 Results

2 February 2017


Upcoming events

9M & Q3 2024 results
Buy-Side Healthcare CEO Summit, Washington DC [Management]
Cowen, Investor Lunch, NYC [Management]

SEC filings

SEC filings are those documents that we are required to file by virtue of our listing on Nasdaq. They contain mainly financial information.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA




Investor enquiries

Main Contacts

Andy Barnett

Andy Barnett

Head of Investor Relations

Morgan Sanford

Morgan Sanford

Oncology

Christer Gruvris

Christer Gruvris

BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income

Lauren Swales

Lauren Swales

Rare Disease

Isabel Gibson

Isabel Gibson

Oncology

Philip Sparks

Philip Sparks

BioPharmaceuticals
(Vaccines & Immune Therapies)

Rachel Korolyshun

Rachel Korolyshun

Rare Disease,
Environment, Social and Governance

Elizabeth Walton

Elizabeth Walton

BioPharmaceuticals
(Respiratory & Immunology), Environment, Social and Governance

Shareholder Helpline